Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
about
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryA non-canonical NRPS is involved in the synthesis of fungisporin and related hydrophobic cyclic tetrapeptides in Penicillium chrysogenumDisease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNSThe Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia.Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunctionTumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian populationAge-Related 1H NMR Characterization of Cerebrospinal Fluid in Newborn and Young Healthy PigletsExploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple SclerosisMetabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkeyHarnessing the integrated stress response for the treatment of multiple sclerosis.Metabolic characterization of the natural progression of chronic hepatitis B.Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis.Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseasesCombined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.Recent advances in metabolomics in neurological disease, and future perspectives.A rough guide to metabolite identification using high resolution liquid chromatography mass spectrometry in metabolomic profiling in metazoansIntegration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.Abnormalities in the Polysomnographic, Adenosine and Metabolic Response to Sleep Deprivation in an Animal Model of Hyperammonemia.Amine Metabolism Is Influenced by Dietary Protein Source.Blood-based metabolic signatures in Alzheimer's disease.Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation.Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.Determination of plasma dibasic amino acids following trimethylsilyl-trifluoroacyl derivatization using gas chromatography-mass spectrometry.Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.Temporal changes in liver tissue metabolome of lambs fed low-quality roughage.Weight loss moderately affects the mixed meal challenge response of the plasma metabolome and transcriptome of peripheral blood mononuclear cells in abdominally obese subjects.Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling.Role of amino acids in rheumatoid arthritis studied by metabolomics.Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat.Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites.Global profiling of the muscle metabolome: method optimization, validation and application to determine exercise-induced metabolic effects
P2860
Q27144251-B0952DBA-A80B-4828-9871-49EC707F7CB1Q28539246-A98DA288-BAB6-42B6-A618-FDD98A34E2A0Q28553584-8484A5A5-514C-43FE-899F-B533C322E589Q30362129-C666AE11-2CC9-42B8-88A7-60A1BAAA580BQ33686011-B69A57D9-F275-4F78-8185-D5E61A98F059Q33781082-FC52565F-ACCE-47A6-B9C4-A54627838A11Q34095665-ABBE09FA-BB9C-46F7-83FD-7FBAB025B746Q35124012-46F81D47-97EB-42F5-B466-F5715D72BFC5Q36071030-972F5F4E-CC58-4B84-BB6B-86CC2E74167FQ36133726-48384FD9-CEA2-4F23-B329-5F00635FF706Q36407218-ED518E7E-D870-4B9B-906A-52C26053DB37Q36614882-50CD564B-21B0-4534-B49C-56F7BB3E42E6Q36689566-0FF133CB-30EF-45E6-B724-6EC1737CC858Q36994664-0569369A-F6CA-451A-8BE9-E9CE0270129FQ37126255-76941556-D5DF-4114-8A79-43C16644D6A7Q37265506-56EF2C46-8189-4497-B340-06BF388BC8D2Q37334196-0F3A72AF-89E0-4721-917A-17C407CB46F4Q37454433-65E8D917-1EF0-4346-BA02-F18E62B829CEQ37733240-FA354E05-7928-4BA6-94C2-419F26332F3BQ38056688-F747A4B8-C4CC-40A2-8EBE-99B329CC7FFCQ38110171-511E6179-1D75-49CB-A19C-8483C5FA72BDQ38201037-0E3B7113-7872-409E-9CD2-093B97C1C60EQ38802998-7BC99314-A9E2-4A7A-81DB-DE4ED8151648Q41411691-7DEF8E34-1471-4C2E-8C40-1D707A26E4F8Q41610814-9E27D428-CF1B-49B1-8B30-3631B0E0E886Q41619597-3A2ACD3A-35B8-478A-A925-54EB32B1972CQ41687826-7377BB21-4B33-4295-99D7-9CD58F394F6DQ41981553-3A993DA6-51A5-421E-B0B7-BF27E1C90616Q46047453-E790FECF-FED0-4DDA-B5D6-E72F0CB25B7EQ47661469-913AB43A-2C4C-471F-8E42-209877DBD5B1Q48141608-B77BBDF4-4374-4D69-AD6B-1A59AD58454EQ49949879-17221786-48A9-439A-B85D-3350984DF683Q50663896-A097A7DE-8353-4B51-9C4C-32DFFE51F526Q50754559-7C1DD571-1CF5-485D-9A1E-FB405519F87EQ51245555-9A5D616A-39F0-4CC6-BBA8-BA99979E9F71Q52661755-41763809-78E9-482F-9F59-6509238B580FQ52698393-E2D8C75A-83BD-410F-A8AD-A8D6EF6C35D1Q55037690-C8EADE40-CA9C-4B8C-A4C9-967EF43FDE88Q55071381-7C7846D7-92F2-4CD5-BAA1-EC10B66E2257Q56981981-859A2DAD-BB41-4A3F-8CD3-F259487B63DB
P2860
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Metabolomics of cerebrospinal ...... t model of multiple sclerosis.
@en
type
label
Metabolomics of cerebrospinal ...... t model of multiple sclerosis.
@en
prefLabel
Metabolomics of cerebrospinal ...... t model of multiple sclerosis.
@en
P2093
P2860
P50
P1433
P1476
Metabolomics of cerebrospinal ...... t model of multiple sclerosis.
@en
P2093
Adrie Dane
Amos Attali
Bas Muilwijk
Ernst Suidgeest
Hans van Aken
Leon Coulier
Shanna Shi
Theo H Reijmers
Theo Luider
Tinka Tuinstra
P2860
P2888
P304
P356
10.1007/S11306-011-0306-3
P577
2011-04-16T00:00:00Z